Search results for "Randomized"

showing 10 items of 2323 documents

Nasal budesonide efficacy for nasal nitric oxide and nasal obstruction in rhinitis

2017

Nasal nitric oxide (nNO) is a noninvasive tool that may be helpful in evaluating the inflammatory status in the upper airways [1]. Previous studies report that nNO is elevated in children with Allergic Rhinitis (AR) [2], especially in perennial sensitized subjects [3], and that it may be affected by topical administration of intranasal steroids (INSs) [4]. This article is protected by copyright. All rights reserved.

MaleBudesonideRhinitis Allergic PerennialImmunologyAdministration Intranasal; Budesonide; Child; Double-Blind Method; Eosinophils; Female; Glucocorticoids; Humans; Male; Nasal Obstruction; Nitric Oxide; Rhinitis Allergic Perennial; Sleep; Pediatrics Perinatology and Child Health; Immunology and Allergy; ImmunologyNitric OxidePediatricsNitric oxidelaw.invention03 medical and health scienceschemistry.chemical_compoundAllergic0302 clinical medicineDouble-Blind MethodRandomized controlled triallawHumansImmunology and AllergyMedicineChild030223 otorhinolaryngologyBudesonideGlucocorticoidsChildrenAdministration IntranasalRhinitisbusiness.industryPerinatology and Child HealthNitric oxide metabolismPerennialNasal obstructionNasal nitric oxideEosinophilsIntranasal030228 respiratory systemchemistryAnesthesiaAdministrationPediatrics Perinatology and Child HealthFemaleNasal administrationSleepbusinessmedicine.drug
researchProduct

Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controll…

2006

To evaluate the efficacy and tolerability of a novel hydrofluoroalkane (HFA) pressurised metered dose inhaler (pMDI) formulation of budesonide (Pulmicort) versus the conventional chlorofluorocarbon (CFC) pMDI formulation in paediatric patients with asthma.This was a Phase III, multicentre, 12-week, double-blind, randomised, parallel-group study involving children (6-12 years of age) with mild to moderate asthma. Patients received either budesonide HFA pMDI or budesonide CFC pMDI 200 mug twice daily, with or without a spacer (NebuChamber/Nebunette). Primary efficacy endpoint: mean percentage change in forced expiratory volume in 1 second (FEV(1)) from baseline to week 12. Secondary efficacy …

MaleBudesonideVital capacityHydrocarbons FluorinatedPeak Expiratory Flow Ratelaw.inventionchemistry.chemical_compoundDouble-Blind MethodRandomized controlled triallawmedicineHumansMetered Dose InhalersBudesonideChildAsthmaChlorofluorocarbonbusiness.industryInhalerGeneral Medicinemedicine.diseaseMetered-dose inhalerAsthmaBronchodilator AgentsTreatment OutcomeAerosol PropellantschemistryTolerabilityAnesthesiaFemaleChlorofluorocarbonsbusinessmedicine.drugCurrent Medical Research and Opinion
researchProduct

Amitriptyline in neuropathic cancer pain in patients on morphine therapy: A randomized placebo-controlled, double-blind crossover study

2002

Aims and Background Amitriptyline is the most common analgesic adjuvant used in cancer patients with neuropathic pain, even though no specific studies have demonstrated a benefit. A randomized placebo-controlled, double-blind crossover study was designed to evidence the effects of amitriptyline in patients with neuropathic cancer pain. Methods Sixteen advanced cancer patients with neuropathic pain on systemic morphine therapy, no longer receiving oncologic treatment, presenting moderate pain (about 4 or more, but less than 7, on a numerical scale of 0-10) in the last week, and given a stable morphine dose in the last 2 days were admitted to the study. During the first week of study, patient…

MaleCancer ResearchAmitriptylineAnalgesicPlaceboNeuropathic painDrug Administration Schedule03 medical and health sciences0302 clinical medicineDouble-Blind Method030502 gerontologyRandomized controlled studyNeoplasmsmedicineHumansAmitriptylineCancer painAgedPain MeasurementAged 80 and overCross-Over StudiesMorphinebusiness.industryGeneral MedicineAnalgesics Non-NarcoticMiddle AgedCrossover studyAnalgesics OpioidTreatment OutcomeOncologyOpioid030220 oncology & carcinogenesisAnesthesiaNeuropathic painQuality of LifeMorphineNeuralgiaDrug Therapy CombinationFemaleAnalgesic0305 other medical scienceCancer painbusinessmedicine.drug
researchProduct

Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer

2017

Background: Limited data exist regarding the correlation between MRI tumour regression grade (mrTRG) and pathological TRG (pTRG) in rectal cancer. Methods: mrTRG and pTRG were compared in rectal cancer patients from two phase II trials (EXPERT and EXPERT-C). The agreement between radiologist and pathologist was assessed with the weighted κ test while the Kaplan–Meier method was used to estimate survival outcomes. Results: One hundred ninety-one patients were included. Median time from completion of neoadjuvant treatment to pre-operative MRI and surgery was 4.1 weeks (interquartile range (IQR): 3.7–4.7) and 6.6 weeks (IQR: 5.9–7.6), respectively. Fair agreement was found between mrTRG and pT…

MaleCancer ResearchPathologySURGERYColorectal cancerACCURACYmedicine.medical_treatmentMagnetic resonance tumour regression gradePREOPERATIVE CHEMORADIATIONKaplan-Meier EstimateTHERAPY030218 nuclear medicine & medical imaging0302 clinical medicineInterquartile rangeRectal cancerNeoadjuvant therapyAged 80 and overCOMPLETE RESPONSEmedicine.diagnostic_testMiddle AgedMagnetic Resonance ImagingNeoadjuvant TherapyOncology030220 oncology & carcinogenesisFemaleRadiologyLife Sciences & BiomedicineRADIOTHERAPYAdultmedicine.medical_specialtyCytodiagnosismagnetic resonance tumour regression gradeDisease-Free Survival03 medical and health sciencesClinical Trials Phase II as TopicmedicinePathological tumour regression gradeHumansOncology & Carcinogenesisrectal cancerPathologicalpathological tumour regression gradeAgedNeoplasm StagingScience & TechnologyRectal Neoplasmsbusiness.industryTOTAL MESORECTAL EXCISIONMagnetic resonance imagingChemoradiotherapy AdjuvantRANDOMIZED PHASE-IIINEOADJUVANT CHEMORADIOTHERAPYmedicine.diseaseClinical trialRadiation therapyClinical StudyFOLLOW-UPbusiness1112 Oncology And CarcinogenesisChemoradiotherapy
researchProduct

A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma

2012

Due to the lacking specificity of symptoms making a correct diagnosis can be a challenge in children with medulloblastoma. This can lead to prediagnostic symptomatic intervals (PSIs) of several weeks to months. It is unknown whether the length of the PSI is associated with an inferior survival outcome in this population.To study the association of PSI with disease stage at diagnosis, tumour control and survival in children with medulloblastoma, prospectively collected data on PSI, clinical, and biological features were analysed in 224 patients diagnosed at the age of 3-18 years and treated within the prospective randomised multicentre trial HIT'91.Patients with lower-stage disease tended to…

MaleCancer ResearchPediatricsmedicine.medical_specialtyDelayed DiagnosisTime FactorsAdolescentPopulation610 Medicine & healthDiseaselaw.inventionRandomized controlled triallawChildhood MedulloblastomaHumansMedicine1306 Cancer ResearchAge of OnsetStage (cooking)Cerebellar NeoplasmsChildeducationMedulloblastomaeducation.field_of_studybusiness.industryCancerPrognosismedicine.diseaseOncology10036 Medical ClinicChild PreschoolFemale2730 OncologyAge of onsetbusinessMedulloblastomaEuropean Journal of Cancer
researchProduct

Effect of self-regulatory behaviour change techniques and predictors of physical activity maintenance in cancer survivors: a 12-month follow-up of th…

2021

Abstract Background Current knowledge about the promotion of long-term physical activity (PA) maintenance in cancer survivors is limited. The aims of this study were to 1) determine the effect of self-regulatory BCTs on long-term PA maintenance, and 2) identify predictors of long-term PA maintenance in cancer survivors 12 months after participating in a six-month exercise intervention during cancer treatment. Methods In a multicentre study with a 2 × 2 factorial design, the Phys-Can RCT, 577 participants with curable breast, colorectal or prostate cancer and starting their cancer treatment, were randomized to high intensity exercise with or without self-regulatory behaviour change technique…

MaleCancer ResearchTime FactorsCancer survivorsLogistic regressionBody Mass Indexlaw.inventionTobacco UseProstate cancerRandomized controlled trialBehavior TherapylawOdds RatioMedicineRC254-282DeterminantsHigh intensityNeoplasms. Tumors. Oncology. Including cancer and carcinogensBehaviour changeMiddle AgedBehavioural supportEndurance TrainingVDP::Medisinske Fag: 700::Helsefag: 800OncologySelf-regulationRegression AnalysisFemaleColorectal NeoplasmsMonth follow upmedicine.medical_specialtyBehaviour changeMaintenancePhysical activityBreast NeoplasmsSelf-ControlConfidence IntervalsGeneticsHumansExerciseSwedenMotivationCancer och onkologibusiness.industryResearchProstatic NeoplasmsCancerResistance Trainingmedicine.diseaseActigraphyCancer and OncologyQuality of LifePhysical therapybusinessFollow-Up StudiesBMC Cancer
researchProduct

Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT‘91

2009

PURPOSE: To analyse long-term outcome and clinical prognostic factors in medulloblastoma. METHODS: We analysed 280 patients with medulloblastoma (3-18 years) included from 1991 to 1997 in the randomised multicentre trial HIT'91 comparing pre-('sandwich') and postradiation ('maintenance') chemotherapy (median follow-up of survivors for 10 years). RESULTS: In 187 patients with complete staging, overall survival (OS) was higher after maintenance compared to sandwich treatment for M0 (10-year OS 91% and 62%, p=0.001) and M1 patients (10-year OS 70% and 34%, p=0.020). In M2/3 disease, 10-year OS was 42% and 45%. Incomplete staging, metastases, younger age and sandwich chemotherapy were independe…

MaleCancer ResearchVincristinePediatricsmedicine.medical_specialtyNeoplasm ResidualAdolescentmedicine.medical_treatmentAntineoplastic AgentsDrug Administration Schedulelaw.inventionMaintenance therapyRandomized controlled triallawmedicineHumansCerebellar NeoplasmsChildSurvival rateNeoplasm StagingProportional Hazards ModelsMedulloblastomaChemotherapybusiness.industryProportional hazards modelNeoplasms Second Primarymedicine.diseaseCombined Modality TherapySurvival RateClinical trialTreatment OutcomeOncologyVincristineChild PreschoolFemaleNeoplasm Recurrence LocalbusinessFollow-Up StudiesMedulloblastomamedicine.drugEuropean Journal of Cancer
researchProduct

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SI…

1995

In a multicentre randomised clinical trial 364 children with biopsy proven medulloblastoma were randomly assigned to receive or not pre-radiotherapy chemotherapy. Children with total or subtotal removal of the tumour, no evidence of invasive brain stem involvement, and no evidence of metastatic disease either within or without the cranium were designated "low risk", those with gross residual tumour, evidence of invasive brain stem involvement or metastases in the central nervous system were designated "high risk". All children were prescribed 55 Gy to the tumour bearing area. "Low risk" children could be randomised to "standard" radiotherapy 35 Gy to the craniospinal axis or "reduced" dose …

MaleCancer ResearchVincristinemedicine.medical_specialtyPediatricsTime FactorsAdolescentmedicine.medical_treatmentProcarbazinelaw.inventionRandomized controlled trialRecurrenceRisk FactorslawAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineProspective StudiesCerebellar NeoplasmsChildProspective cohort studyMedulloblastomabusiness.industryInfantRadiotherapy Dosagemedicine.diseaseCombined Modality TherapySurvival AnalysisSurgeryRadiation therapyClinical trialOncologyChild PreschoolPediatrics Perinatology and Child HealthFemalebusinessCraniospinalMedulloblastomamedicine.drugMedical and Pediatric Oncology
researchProduct

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung ca…

2005

Purpose To study the prognostic value for overall survival of baseline assessment of functional status, comorbidity, and quality of life (QoL) in elderly patients with advanced non—small-cell lung cancer treated with chemotherapy. Patients and Methods Data from 566 patients enrolled onto the phase III randomized Multicenter Italian Lung Cancer in the Elderly Study (MILES) study were analyzed. Functional status was measured as activities of daily living (ADL) and instrumental ADL (IADL). The presence of comorbidity was assessed with a checklist of 33 items; items 29 and 30 of the European Organisation for Research and Treatment of Cancer (EORTC) core questionnaire QLQ-C30 (EORTC QLQ-C30) wer…

MaleCancer Researchmedicine.medical_specialtyLung NeoplasmsActivities of daily livingHealth StatuscarcinomaVinblastineVinorelbineDeoxycytidineolder peopleQuality of lifeInstrumental activitieCarcinoma Non-Small-Cell LungInternal medicineActivities of Daily LivingAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLung cancerAgedAged 80 and overvalidationProportional hazards modelbusiness.industryQLQ-C30Age FactorsCancerVinorelbineclinical trialPrognosismedicine.diseaseGemcitabineComorbidityhumanitiescomorbidityOncologyQuartileQuality of LifePhysical therapyimpactGeriatric oncologyFemalebusinessRandomized-trialmedicine.drug
researchProduct

Criteria for the determination of maximal oxygen uptake in patients newly diagnosed with cancer : Baseline data from the randomized controlled trial …

2020

IntroductionMaximal oxygen uptake ([Formula: see text]) is a measure of cardiorespiratory fitness often used to monitor changes in fitness during and after treatment in cancer patients. There is, however, limited knowledge in how criteria verifying [Formula: see text] work for patients newly diagnosed with cancer. Therefore, the aim of this study was to describe the prevalence of fulfillment of typical criteria verifying [Formula: see text] and to investigate the associations between the criteria and the test leader's evaluation whether a test was performed "to exhaustion". An additional aim was to establish new cut-points within the associated criteria.MethodsFrom the Phys-Can randomized c…

MaleCancer Treatmentlaw.inventionCohort Studies0302 clinical medicineRandomized controlled trialHeart RateReference ValueslawNeoplasmsMedicine and Health SciencesPublic and Occupational HealthTreadmillRespiratory exchange ratioRating of perceived exertioneducation.field_of_studyMultidisciplinaryQRVO2 maxMiddle AgedVDP::Medisinske Fag: 700::Idrettsmedisinske fag: 850Sports ScienceExercise TherapyChemistryTreatment OutcomeOncologyCardiorespiratory FitnessResearch Design030220 oncology & carcinogenesisPhysical SciencesMedicineFemaleResearch ArticleChemical Elementsmedicine.medical_specialtySciencePhysical ExertionPopulationCardiologyResearch and Analysis Methods03 medical and health sciencesOxygen ConsumptionDiagnostic MedicineInternal medicineHeart rateCancer Detection and DiagnosismedicineHumansSports and Exercise MedicineeducationExerciseAgedColorectal Cancerbusiness.industryBiology and Life SciencesCancers and NeoplasmsCardiorespiratory fitnessPhysical Activity030229 sport sciencesOxygenROC CurvePhysical FitnessExercise Testbusinesshuman activities
researchProduct